Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing

Summary

A rapid bacterial pellet preparation from a positive blood culture can be used as a sample for applications such as identification by MALDI-TOF, Gram staining, antibiotic susceptibility testing and PCR-based test. The results can be rapidly communicated to clinicians to improve the outcome of patients suffering from bloodstream infections.

Abstract

Bloodstream infections and sepsis are a major cause of morbidity and mortality. The successful outcome of patients suffering from bacteremia depends on a rapid identification of the infectious agent to guide optimal antibiotic treatment. The analysis of Gram stains from positive blood culture can be rapidly conducted and already significantly impact the antibiotic regimen. However, the accurate identification of the infectious agent is still required to establish the optimal targeted treatment. We present here a simple and fast bacterial pellet preparation from a positive blood culture that can be used as a sample for several essential downstream applications such as identification by MALDI-TOF MS, antibiotic susceptibility testing (AST) by disc diffusion assay or automated AST systems and by automated PCR-based diagnostic testing. The performance of these different identification and AST systems applied directly on the blood culture bacterial pellets is very similar to the performance normally obtained from isolated colonies grown on agar plates. Compared to conventional approaches, the rapid acquisition of a bacterial pellet significantly reduces the time to report both identification and AST. Thus, following blood culture positivity, identification by MALDI-TOF can be reported within less than 1 hr whereas results of AST by automated AST systems or disc diffusion assays within 8 to 18 hr, respectively. Similarly, the results of a rapid PCR-based assay can be communicated to the clinicians less than 2 hr following the report of a bacteremia. Together, these results demonstrate that the rapid preparation of a blood culture bacterial pellet has a significant impact on the identification and AST turnaround time and thus on the successful outcome of patients suffering from bloodstream infections.

Introduction

Bloodstream infections and sepsis in hospitalized patients are a major cause of morbidity and mortality. Thus, mortality related to bloodstream infections is observed in about 14% to 37% of hospitalized patient and may increase to 35% in intensive care units patients ^1-3. The rapid identification of the infectious agent is pivotal to guide optimal antimicrobial treatment and to increase the successful outcome of antimicrobial therapy ^4,5. The rapid analysis of Gram stains from positive blood culture has already a significant impact on the adaptation of antimicrobial therapy ^6,7 but accurate identification of the infectious agent is required to provide the best adapted antibiotic treatment to the patients. For instance, different antibiotic treatment regimens have to be implemented following bacteremia with enterococci and streptococci that are difficult to distinguish by Gram staining. Similarly, identification at the species level is required to detect Gram negative enterobacteria encoding a chromosomal ampC gene which confer an increased resistance to β-lactams ⁸.

With a positive blood culture, the conventional diagnostic approach is to subculture the infectious agent on different agar plates, which requires several hours of additional incubation prior identification with various approaches including biochemical tests, growth on different selective media and automated microbial identification systems. The time to results of a conventional diagnostic approach is of about 1 to 3 days.

The emergence of the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) technology for rapid identification of microorganisms has provided a new tool to quickly identify microorganisms from colonies grown on agar plates but also directly from positive blood cultures (Figure 1) ^9-12. The use of MALDI-TOF to identify an infectious agent from blood cultures has significantly reduced the time to results to a few minutes instead of the hours and days required by traditional methods. As discussed by Croxatto et al. ¹³, the efficiency of MALDI-TOF identification relies on different parameters including the microorganism’s purity and quantity. These two criteria are easily obtained from discrete colonies grown on agar plates but required a pre-analytical treatment for bacterial enrichment and purification from complex samples such as blood culture, which contain multiple cellular and protein components that may interfere with MALDI-TOF identification.

Various microorganisms’ isolation methods from blood culture have been used in a number of studies including saponin or other mild detergents method for bacterial extraction ^9,14, serum separator method ¹⁰, lysis centrifugation methods ¹² and commercially solutions such as the sepsityper kit. Our bacteriology diagnostic laboratory has developed a simple blood-culture bacterial pellet preparation based on ammonium chloride erythrocyte-lysis which allow fast identification of bacteria and yeast by MALDI-TOF and automated identification systems (Figure 2) ¹⁵. This blood-culture pellet preparation also provide a sample for other direct downstream applications such as Gram staining, automated PCR-based diagnostic tests such as POCT-PCRs for the rapid detection of methicillin-resistant Staphyloccocus aureus (MRSA), and antibiotic susceptibility testing with automated AST systems and/or by disk diffusion assays on agar plates (Figure 3).

In this work, we describe the different steps for the preparation of the blood-culture bacterial pellet as explained by Prod’hom et al.¹⁵ (Figure 4). We will also describe the protocols for three of the main applications that can be performed on the blood culture pellet: Identification by MALDI-TOF ¹⁵, identification (ID) and antibiotic susceptibility testing (AST) with the automated systems ¹⁶ for Enterobacteriaceae and staphylococci and automated PCR-based diagnostic test for the detection of MRSA ¹⁷.

Protocol

This protocol has been developed and validated following the research and development processes and ethical rules of our institution before being implemented as a routine tool.

1. Preparation of a Blood Culture Bacterial Pellet by Ammonium Chloride Erythrocyte-lysing Procedure

1. Preparation of a positive blood culture for subsequent centrifugation.
   1. Sterilize the blood culture cap. Add 70% ethanol on the cap of the bottle and burn it.
      NOTE: Do not perform this step under a laminar flow hood.
   2. Move the bottle to a laminar flow hood. Collect 5 ml of the blood culture with a 20 G syringe.
   3. Add the 5 ml of blood culture in a 50 ml centrifuge tube containing 45 ml of sterile water (H₂O) and mix the sample.
2. Preparation of a blood culture bacterial pellet by lysis centrifugation.
   1. Centrifuge the sample at 1,000 x g for 10 min at RT.
   2. Remove the supernatant (which contains mainly H₂O and blood cells) with a laboratory vacuum pump.
   3. Resuspend the pellet in 1 ml of home-made ammonium chloride lysing solution (0.15 M NH₄Cl, 1 mM KHCO₃). Break down the pellet by scraping and by vortexing the tube and centrifuge the sample at 140 x g for 10 min at RT.
   4. Discard the supernatant which mainly contains red blood cells debris.
      1. If the pellet remained hemorrhagic, resuspend the pellet in 2 ml of sterile and distilled H₂0 to further lyse residual red blood cells and to wash the pellet. Centrifuge the sample at 140 x g for 10 min at RT and discard the supernatant.
   5. Resuspend the pellet in 200 µl of H₂O
3. Subculture of blood culture on various selective and non-selective agar media.
   1. Collect 1 ml of the blood culture with a 20 G syringe.
   2. Inoculate 1 drop of blood culture into four quadrants on blood agar, chocolate agar, McConkey agar and Schaedler agar.
   3. Incubate at 37 °C the blood agar and chocolate agar plates in a 5% CO₂ atmosphere, the McConkey agar in a normal atmosphere and the Schaedler agar plate in anaerobic conditions.
   4. Follow bacterial growth on the different media.
   5. Check for bacterial purity.

2. Identification by MALDI-TOF MS

1. Direct identification from the blood pellet.
   1. Transfer 1 µl of the blood pellet on a MALDI target plate and let it dry on a 42 °C heating platform.
   2. Overlay the sample with 1 µl 70% formic acid and let it dry on a 42 °C heating platform.
   3. Overlay the sample with 1 µl of MALDI matrix (saturated solution of α-cyano-4-hydroxycinnamic acid in 50% acetonitrile-2.5% trifluoroacetic acid) and let it dry on a 42 °C heating platform.
   4. Proceed to MALDI-TOF MS analysis with a MALDI-TOF MS system as described by the manufacturers.
   5. If the identification score is invalid at the species level (for instance with a score < 2), perform a protein extraction of the blood pellet sample.
2. Identification after protein extraction from the blood culture pellet.
   1. Mix 20 µl of the pellet with 1 ml of 70% ethanol and centrifuge at 13,000 x g for 2 min at RT.
   2. Discard the supernatant and add 25 µl of 70% formic acid and 25 µl of 100% acetonitrile to the pellet. Vortex vigorously to resuspend the pellets. Resuspend tough pellets by breaking them down with pipette tips before vortexing.
   3. Centrifuge at 13,000 x g for 2 min at RT. Transfer 1 µl of the supernatant (which contain extracted proteins) on a MALDI target plate and let it dry on a 42 °C heating platform. Proceed as described in 2.1.2.

3. Bacterial Identification and Antibiotic Susceptibility Testing with an Automated Microbial System

1. Preparation of a bacterial suspension for bacterial identification and AST with an automated microbial system.
   1. Prepare a plastic tube containing 3 ml of sterile 0.45% NaCl solution compatible with the automated microbial system.
   2. Add a sufficient volume of the blood culture pellet in the 0.45 % NaCl solution to obtain a bacterial suspension corresponding to a McFarland turbidity of 0.6 to 0.8. Measure the turbidity using a densitometer machine.
      NOTE: The volume of the blood culture bacterial pellet varies from 50 to 200 µl to achieve a McFarland turbidity of 0.6 to 0.8.
2. Inoculate the automated Gram-positive (GP) or Gram-negative (GN) cards for identification and the automated AST cards for antimicrobial susceptibility testing of Gram-positive cocci and Gram-negative bacteria as described by the manufacturer.
   NOTE: Identification with GP or GN cards is not applied if MALDI-TOF MS identification score value is >2. Check the purity of the bacterial suspension by subculturing the bacterial suspension on blood agar (GP and GN) and MacConkey agar (GN) plates.

4. Antibiotic Susceptibility Testing by Disk Diffusion Assay

The disk diffusion assay is described by the European committee on antimicrobial susceptibility testing (EUCAST, Version 3.0, April 2013, www.eucast.org).

1. Preparation of a bacterial suspension to perform antimicrobial susceptibility testing by disk diffusion assay.
   1. Prepare a glass tube containing 3 ml of sterile 0.9% NaCl solution.
   2. Add a sufficient volume of the blood culture pellet in the 0.9% NaCl solution to obtain a bacterial suspension corresponding to a McFarland turbidity of 0.5. Measure the turbidity using a densitometer machine.
      NOTE: The volume of the blood culture bacterial pellet varies from 50 to 200 µl to achieve a McFarland turbidity of 0.6 to 0.8.
   3. Vortex the bacterial suspension.
2. Inoculation of bacterial suspension onto Mueller-Hinton agar (MH) or Mueller-Hinton agar-fastidious organisms agar (MHF) (MH supplemented with 5% defibrinated horse blood and 20 mg/L of β-Nicotinamide adenine dinucleotide).
   1. Dip a sterile cotton swab in the bacterial suspension and gently remove excess fluid by turning the swab on the inside wall of the glass tube.
   2. Spread the bacterial suspension evenly onto the entire surface of the MH/MHF agar plate by swabbing in three directions or by using an automated plate rotator.
3. Application of antimicrobial disks on inoculated agar plates.
   1. Apply closely the disks on the surface of the dried inoculated agar plates manually or by using a susceptibility disk dispenser.
   2. Incubate the plate at the appropriate temperature and atmosphere as described in the antimicrobial susceptibility testing EUCAST disk diffusion method (Version 3.0, April 2013, www.eucast.org).

5. Automated PCR-based Diagnostic Test for the Detection of MRSA

1. Using a micropipette, transfer 50 µl of the blood culture pellet into the sample reagent vial provided with the MRSA automated PCR-based diagnostic test kit and vortex during 20 sec.
2. Using a 1 ml micropipette, dispense the sample into the specimen port of the cartridge. Insert the cartridge into the automated PCR system and start the assay as described by the manufacturer.

Results

In the study performed by Prod’hom et al.¹⁵, bacterial pellets obtained by ammonium chloride lysis centrifugation of 122 positive blood culture from 78 patients were analyzed by MALDI-TOF MS. Out of 122 positive blood culture, 95 (77.9%) were correctly identified at the species level and one (0.8%) at the genus level. The remaining 26 (21.3%) blood culture pellets gave no reliable identification by MALDI-TOF. Among those, 21 were gram positive bacteria including 13 streptococci and 5 coagulase-negativ...

Discussion

Compared to conventional positive blood culture diagnostic approaches, the rapid acquisition of a bacterial pellet by using the ammonium chloride lysis centrifugation approach reduce the time to report identification by 16 to 24 hr and the time to report AST by 24 to 48 hr (Figures 1 and 3).

Rapid introduction of appropriate antibiotic therapy is pivotal to improve the outcome of patients suffering from bloodstream infections. Thus, early identification of the infectious agent...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
20 G needle	Terumo, Leuven, Belgium	NN-2038R
50 ml Falcon tube	BD, Franklin Lakes, NJ, USA	352070	50 ml centrifuge tubes
Ammonium chlorure	Merck, Darmstadt, Germany	101145
Potassium hydrogen carbonate	Fluka, St. Louis, MO, USA	60340
Formic acid	Sigma-Aldrich, St. Louis, MO, USA	F0507	Flammable, corrosive
α-Cyano-4-hydroxycinnamic acid	Fluka, St. Louis, MO, USA	70990	Acute toxicity
Acetonitrile	Sigma-Aldrich, St. Louis, MO, USA	271004	Flammable, acute toxicity
Trifluoroacetic acid	Sigma-Aldrich, St. Louis, MO, USA	T6508	Corrosive, acute toxicity
Vitek 2 60 instrument	Biomérieux, Marcy-l'Etoile, France	27202	automated microbial system instrument
Vitek 2 Gram-positive (GP) card	Biomérieux, Marcy-l'Etoile, France	21342	automated GP  identification card
Vitek 2 AST-P580 card	Biomérieux, Marcy-l'Etoile, France	22233	automated microbial AST system
Vitek 2 Gram-negative (GN) card	Biomérieux, Marcy-l'Etoile, France	21341	automated GN  identification card
Vitek 2 AST-N242 card	Biomérieux, Marcy-l'Etoile, France	413391	automated microbial AST system
Xpert MRSA	Cepheid, Sunnyvale, Ca, USA	GXMRSA-100N-10	nucleic acid amplification technology MRSA
GeneXpert IV instrument	Cepheid, Sunnyvale, Ca, USA	GXIV-4-D	nucleic acid amplification technology instrument
Microflex LT MALDI-TOF MS instrument	Bruker Daltonics, Bremen, Germany	BDAL microflex LT/SH
MSP 96 target steel BC	Bruker Daltonics, Bremen, Germany	280799	MALDI target plate
Densitometer Densicheck instrument	Biomérieux, Marcy-l'Etoile, France	27208
MALDI Sepsityper kit 50	Bruker Daltonics, Bremen, Germany	8270170
Mac Conkey agar	Biolife, Milano, Italy	4016702
Mueller-Hinton agar	Oxoid, Hampshire, England	CM0337	Mueller-Hinton agar (MH)
MHF agar	Biomérieux, Marcy-l'Etoile, France	43901	Mueller-Hinton agar-fastidious organisms agar (MHF)
BD columbia III agar	BD, Franklin Lakes, NJ, USA	254071	blood agar
BD chocolate agar	BD, Franklin Lakes, NJ, USA	254089	chocolate agar
BD schaedler agar	BD, Franklin Lakes, NJ, USA	254084	Schaedler agar